Loading...
U.S. futures are surging following a landmark 'framework deal' regarding Greenland, effectively dismantling the threat of retaliatory tariffs against Europe. Markets are pivoting aggressively toward risk-on assets, further fueled by President Trump's imminent announcement of a new Federal Reserve Chair.
⚠️ Educational Content Only: This is not financial advice. Trading options involves significant risk. Consult a licensed professional before making investment decisions.
U.S. futures are surging following a landmark 'framework deal' regarding Greenland, effectively dismantling the threat of retaliatory tariffs against Europe. Markets are pivoting aggressively toward risk-on assets, further fueled by President Trump's imminent announcement of a new Federal Reserve Chair.
Historically, January's third week (Jan 15-21) has been prone to high volatility and tech liquidations, notably the 2022 'Netflix Crash.' However, 2026 is bucking the trend as geopolitical de-escalation overrides seasonal cooling.
The removal of the Greenland-related tariff overhang has triggered a massive short-covering rally in global trade-exposed sectors. Semiconductors are leading the charge, with the SOXX rallying while the inverse $SOXS has plummeted -5.8%. This pivot shifts the market narrative from trade-war defensiveness to growth-oriented buying. Investors are now laser-focused on the vetting process for the next Fed Chair, led by Bessent and Lutnick, which is expected to provide further clarity on the 2026 interest rate trajectory.
Despite mixed earnings from staples like $ABT and $MKC, institutional flow is concentrating in high-conviction growth. Materials remains the strongest sector, supported by names like $ALB and $SQM. In the Biotech space, $RVMD carries a top Alpha Signal with an institutional target of $140, driven by significant call-buying activity. Meanwhile, $MRNA is seeing explosive momentum, surging +15.8% on breakthrough melanoma vaccine data, signaling a broader 'risk-on' appetite in the healthcare sector.
Skyrocketing +15.8% on high volume following clinical optimism for its melanoma vaccine and 2026 pipeline outlook.
Dumping -5.8% as the broader semiconductor sector rallies on the removal of trade tariff threats.
Materials sector standout, gaining a massive +127.55% as penny-stock momentum returns to the risk-on environment.
Trading lower by -3.5% after lukewarm guidance in its medical products division overshadowed the broader market rally.
The information provided on this platform is for educational purposes only and should not be considered as financial advice, investment recommendations, or trading signals. Past performance does not guarantee future results. You should conduct your own research and consult with a licensed financial advisor before making any investment decisions. Trading options involves substantial risk of loss.
Data Delayed 15 Minutes.
For Educational Purposes Only.
Not Investment Advice.
© 2026 OptionsIQ. All rights reserved.
⚠️ NOT FINANCIAL ADVICE - For educational purposes only.